STAT1 and atherosclerosis: With regard to the regulatory effect of LDLs on JAK/STAT signaling in human diseases, a microarray analysis indicated that ox-LDLs in atherosclerosis strongly affect the JAK-STAT signaling pathway by acting through STAT1 and STAT2 [32, 33].